Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Tuesday, December 30, 2014

Israel: New Hep C treatment tops formulary spending list

Ministry of Health recommends NIS 300 million worth of medications to be subsidized by state in 2015 

The Ministry of Health published Tuesday a list of drugs, medications and new treatments set to be fully or partially subsidized by the state in the year 2015. A special Health Ministry committee debated the formulary for several weeks, finally selecting the treatments late Monday night from nearly NIS 3 billion (about $860 million) worth of medications.

The committee’s recommendations are expected to be passed into law in early 2015.

Close to NIS 300 million (close to $86 million) will be allocated towards the various medications, with nearly a third of the budget dedicated to a new treatment for Hepatitis C.
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)